Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Genelux Corporation - Common Stock (NQ:GNLX)

2.740 +0.180 (+7.03%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 16, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	402,379
Open	2.600
Bid (Size)	2.700 (100)
Ask (Size)	2.850 (500)
Prev. Close	2.560
Today's Range	2.548 - 2.800
52wk Range	1.988 - 8.535
Shares Outstanding	38,051,771
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners

January 12, 2026

From Genelux Corporation

Via GlobeNewswire

These stocks are gapping in today's session ↗

January 08, 2026

Via Chartmill

Performance

YTD	-39.8%	-39.8%
1 Month	-34.6%	-34.6%
3 Month	-57.9%	-57.9%
6 Month	-21.9%	-21.9%
1 Year	+11.4%	+11.4%

More News

Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock

January 08, 2026

From Genelux Corporation

Via GlobeNewswire

Get insights into the top gainers and losers of Thursday's pre-market session. ↗

January 08, 2026

Via Chartmill

The Great Thaw: Biotech Fundraising Surges as Monte Rosa and Genelux Tap Reopening Markets

January 07, 2026

Via MarketMinute

Genelux Corporation Announces Proposed Public Offering of Common Stock

January 07, 2026

From Genelux Corporation

Via GlobeNewswire

Genelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials

January 05, 2026

From Genelux Corporation

Via GlobeNewswire

Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer

January 02, 2026

From Genelux Corporation

Via GlobeNewswire

Genelux Corporation to Participate in a Fireside Chat at Piper Sandler 37th Annual Healthcare Conference

November 26, 2025

From Genelux Corporation

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 06, 2025

Via Benzinga

Genelux Corporation Reports Third Quarter 2025 Financial Results and Provides General Business Updates

November 05, 2025

From Genelux Corporation

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 23, 2025

Via Benzinga

Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference

September 02, 2025

From Genelux Corporation

Via GlobeNewswire

Genelux Corporation Reports Second Quarter 2025 Financial Results and Provides General Business Updates

August 07, 2025

From Genelux Corporation

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 21, 2025

Via Benzinga

Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development

July 07, 2025

From Genelux Corporation

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 08, 2025

Via Benzinga

Genelux Corporation Reports First Quarter 2025 Financial Results and Provides General Business Updates

May 06, 2025

From Genelux Corporation

Via GlobeNewswire

Genelux Corporation to Participate in a Fireside Chat at the Citizens Life Sciences Conference

May 01, 2025

From Genelux Corporation

Via GlobeNewswire

Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

March 28, 2025

From Genelux Corporation

Via GlobeNewswire

CurrencyNewsBreaks – Titan Partners Group LLC Acts as Sole Bookrunner for $10.5M Underwritten Offering

March 28, 2025

Via Investor Brand Network

Genelux Corporation Announces Pricing of $10.5 Million Underwritten Offering of Common Stock

March 25, 2025

From Genelux Corporation

Via GlobeNewswire

Genelux Announces Alignment with FDA on Key Elements of the Approval Pathway for Olvi-Vec in Platinum Resistant/Refractory Disease

March 25, 2025

From Genelux Corporation

Via GlobeNewswire

Genelux and Newsoara Announce Positive Preliminary Phase 1b/2 Data of Olvi-Vec in Advanced Small-Cell Lung Cancer

March 25, 2025

From Genelux Corporation

Via GlobeNewswire

Genelux Corporation Announces New Chief Financial Officer

February 03, 2025

From Genelux Corporation

Via GlobeNewswire

Frequently Asked Questions

Is Genelux Corporation - Common Stock publicly traded?

Yes, Genelux Corporation - Common Stock is publicly traded.

What exchange does Genelux Corporation - Common Stock trade on?

Genelux Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Genelux Corporation - Common Stock?

The ticker symbol for Genelux Corporation - Common Stock is GNLX on the Nasdaq Stock Market

What is the current price of Genelux Corporation - Common Stock?

The current price of Genelux Corporation - Common Stock is 2.740

When was Genelux Corporation - Common Stock last traded?

The last trade of Genelux Corporation - Common Stock was at 01/16/26 04:00 PM ET

What is the market capitalization of Genelux Corporation - Common Stock?

The market capitalization of Genelux Corporation - Common Stock is 104.26M

How many shares of Genelux Corporation - Common Stock are outstanding?

Genelux Corporation - Common Stock has 104M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.